Sample solvents that wreck a peak shape

Peak shape is often decided in the second the sample meets the bed. This page names the solvent words people use when that meeting goes badly, and the decision each word should trigger. The separation modes underneath those words are in chromatography methods in life-science labs.

Solvent strength

Solvent strength is how strongly the mobile phase pulls an analyte off the stationary phase. In the distribution IUPAC describes, a stronger solvent shifts the analyte toward the moving phase, so it travels farther per unit time. What counts as strong depends on the mode. On reversed phase, a higher fraction of acetonitrile or methanol is usually stronger for a hydrophobic analyte. On normal phase, a more polar modifier is usually stronger. On ion exchange, higher competing salt is the analogous idea. A sample solvent is strong, in this glossary, when it is a better eluent than the mobile phase sitting in the column at the moment of injection.

The starting mobile phase is the composition at injection, not the average of the gradient and not the composition at the end of the run. A peptide dissolved in 50 percent acetonitrile and injected into a column equilibrated at 2 percent acetonitrile meets a weak bed while wrapped in a strong droplet. That mismatch is the whole failure.

Focusing

Focusing is the useful version of the same physics. Analyte dissolved in a solvent weaker than the mobile phase, or in the mobile phase itself, slows down as soon as it hits the head of the bed. The band compresses. A modest injection volume then produces a narrow peak. Diluting a strong sample with starting mobile phase is a focusing repair, provided the analyte stays soluble and the larger injection still fits the column. There is a limit. A very large weak injection eventually broadens peaks by volume alone. Column volume is the scale: injection volumes of a small percentage of the bed are ordinary on HPLC. Follow the column note when it gives a tighter ceiling.

Fronting

Fronting is an asymmetric peak whose mass leans toward earlier times. The leading edge is distorted and the tail is comparatively sharp. A strong sample solvent produces fronting when part of the band moves before it has a chance to focus. Overloading the stationary phase produces a similar lean, because the isotherm flattens and extra mass spends more time in the mobile phase. The branch is empirical and cheap. Inject less, in a weaker solvent. Restored symmetry means you can keep the column. Persistent fronting on a light load in weak solvent means the bed, the fittings, or a void at the inlet needs attention.

Breakthrough

Breakthrough is analyte reaching the detector in the void window because it did not bind at the inlet. In a solvent-mismatch story, the strong plug is a moving pocket of eluent. In a capacity story, the sites were full. In a chemistry story, the mode never retained that molecule: a protein in the flow-through of an ion-exchange column, or a polar metabolite in the void of a C18 column. The fraction in the void is then the sample, and the later tubes are empty of it. Assay the early fraction before you dry down the "peak" that was only a solvent disturbance. A standard prepared in weak solvent that still breaks through points at chemistry or a bypassed column, not at your diluent.

Split peaks

A split peak shows two apices where the method should show one. The solvent version is two travel histories inside one injection, as the focusing paragraph and the breakthrough paragraph split one compound between them. You will also see splits from a column void, a partially blocked frit, or two genuine compounds. Watch the standard. A standard in weak solvent that is a single apex, beside a sample in strong solvent that is split, implicates the sample solvent. A standard that is itself split implicates the bed. Mass spectrometry resolves the remaining doubt when the two apices have different masses. A single mass at two times is compatible with a solvent artefact. HUPO reporting practice still applies if you promote that observation into an identification. The sequence you compare against can come from UniProt. The split itself is not the identification.

Tailing, named so it is not used for the wrong shape

Tailing leans the other way: a sharp front and a long return to baseline. Sample solvent can contribute if the analyte precipitates at the inlet and redissolves slowly, but the classic causes are extra retention sites and overload of a different isotherm shape. Call the shape by the edge that is distorted. A troubleshooting note that says "bad peak" will send the next person to dilute a solvent that was already weak, while the column was the problem.

Injection volume

Injection volume is the delivered volume, not the number on the method line, if the syringe or pipette was mis-set. ISO 8655-1 covers the class of piston-operated volumetric apparatus. A 50 microlitre injection of a strong solvent disturbs a narrow HPLC column more than a 5 microlitre injection of the same solvent. Reducing volume is a fair test. It is an incomplete test if the droplet is still stronger than the start, because a small strong plug can still open a channel of elution at the inlet.

A short decision path

Inject the standard in starting mobile phase. If it fronts or splits, the column or the instrument is the subject, and solvent exchange on the sample will not save the day. If the standard is symmetrical and the sample is not, exchange or dilute the sample into the starting composition and cut the injection volume. Reinject. If both apices collapse into the standard's window, pool fractions from that repaired run only. Fractions taken under a split peak mix the early artefact with the real retention and undo the repair. If dilution causes precipitation, the solvent exchange belongs in a vial you can centrifuge, not inside the frit.

Research use

These shapes are diagnostic of the injection, not of a patient's status and not of a product release. Solvents strong enough to wreck a peak are often the flammable or toxic ones. Handle them under the chemical controls you have assessed. A biological sample dissolved in organic solvent may still carry biological risk. Institutional rules decide that, not the peak shape.

Enquiry

Tell the reader of your request what the sample is dissolved in, what the gradient or isocratic start is, how large the injection is relative to column volume, and whether the standard in weak solvent looks clean. Ask for column chemistry and for any solvent-exchange step the hardware assumes. Use the scientific instruments catalogue and the quote request. Where the sample is a protein fraction going onto HPLC, the custom protein expression and purification reference can carry the method question as a discussion. ---